Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

DD

DuPont Announces 1-for-3 Reverse Stock Split

DuPont said its board approved a 1-for-3 reverse stock split of its common stock, with the change set to take effect at 12:01 a.m. ET on June 24, 2026. The company’s shares are expected to start trading on a split-adjusted basis that day under the same ticker, DD.

The split will reduce the number of authorized common shares from 1,666,666,667 to 555,555,556. Based on the share count as of May 22, 2026, DuPont said outstanding shares would fall from about 405,058,202 to about 135,019,401, before rounding for fractional shares. No fractional shares will be issued; holders entitled to fractions will receive cash instead.

DuPont also said the reverse split will trigger proportional adjustments to equity awards, including stock options and restricted stock units, as well as outstanding warrants and other convertible securities.

Alongside the stock split announcement, DuPont reaffirmed its 2026 guidance for net sales, operating EBITDA and adjusted EPS. It said it expects second-quarter 2026 adjusted EPS of about $1.75 after the split adjustment, compared with prior guidance of about $0.59. For full-year 2026, adjusted EPS guidance was raised on a split-adjusted basis to $7.02 to $7.16, versus prior guidance of $2.35 to $2.40 before the split adjustment.

DuPont said the split-adjusted guidance reflects a weighted average diluted share count of about 137 million shares for both the second quarter and full year 2026. As a result of these announcements, the company's shares have moved -0.21% on the market, and are now trading at a price of $47.15. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS